Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
AIM ImmunoTech Inc. (AIM)
USD0.26
0.00 (-1.20%)
US AMEX Healthcare Biotechnology
Address
2117 SW Highway 484 34473
Ocala, FL, US
Ocala, FL, US
CEO
Thomas K. Equels
Website
aimimmuno.com
IPO
1995-11-02
CIK 946644 ISIN US00901B3033
Description
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company, originally incorporated in 1966, was formerly known as Hemispherx Biopharma, Inc. until its name change in August 2019.
News Sentiment (7d)
5 articles
- Coiled Therapeutics develops improved formulation of experimental cancer drug ahead of trial expansion Proactive Investors
- AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program Globe News Wire
- AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program GlobeNewsWire
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.26
0.00 (-1.20%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
28M
Beta
1.17
Float Shares
2.78M
Free Float %
81.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.94% | -25.37% | -53.60% | -78.00% | -82.43% | -77.61% | -97.01% | -99.46% | -99.87% | -100.00% | -97.06% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
0.26
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-76.32
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-48.2% Q1'26: +37.5% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+23.2% Q1'26: +63.9% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-13,643.2% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-11,961.4% Q1'26: -10,118.2% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +267.3% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+4.8% Q1'26: +124.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.47× Q1'26: -0.04× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
133.0K
est: 200.0K (-33.5%)
|
92.0K
est: 87.31M (-99.9%)
|
437.0K
est: 197.50M (-99.8%)
|
367.0K
est: 227.0K (+61.7%)
|
140.0K
est: 240.7K (-41.8%)
|
163.0K
est: 167.7K (-2.8%)
|
135.0K
est: 120.7K (+11.9%)
|
141.0K
est: 239.7K (-41.2%)
|
202.0K
est: 201.0K (+0.5%)
|
170.0K
est: 200.0K (-15.0%)
|
88.0K
est: 100.0K (-12.0%)
|
100.0K
100.0K – 100.0K
+0.0% YoY
|
100.0K
100.0K – 100.0K
+0.0% YoY
|
51.04M
51.04M – 51.04M
+50,943.0% YoY
|
74.5K
74.5K – 74.5K
-99.9% YoY
|
| EBITDA |
-14.25M
est: -200.0K (-7,026.0%)
|
-6.33M
est: -87.31M (+92.7%)
|
-7.12M
est: -197.50M (+96.4%)
|
-8.41M
est: -227.0K (-3,602.6%)
|
-8.15M
est: -240.7K (-3,285.6%)
|
-13.00M
est: -167.7K (-7,650.5%)
|
-18.29M
est: -120.7K (-15,053.3%)
|
-19.87M
est: -239.7K (-8,190.3%)
|
-28.72M
est: -201.0K (-14,190.5%)
|
-16.49M
est: -200.0K (-8,144.5%)
|
-10.32M
est: -100.0K (-10,216.0%)
|
-100.0K
-100.0K – -100.0K
+0.0% YoY
|
-100.0K
-100.0K – -100.0K
+0.0% YoY
|
-51.04M
-51.04M – -51.04M
-50,943.0% YoY
|
-74.5K
-74.5K – -74.5K
+99.9% YoY
|
| EBIT |
-15.23M
est: -200.0K (-7,513.5%)
|
-7.50M
est: -87.31M (+91.4%)
|
-8.12M
est: -197.50M (+95.9%)
|
-9.33M
est: -227.0K (-4,007.9%)
|
-8.98M
est: -240.7K (-3,630.1%)
|
-13.73M
est: -167.7K (-8,087.7%)
|
-19.06M
est: -120.7K (-15,695.5%)
|
-19.45M
est: -239.7K (-8,013.3%)
|
-28.96M
est: -201.0K (-14,309.0%)
|
-16.74M
est: -200.0K (-8,267.5%)
|
-10.53M
est: -100.0K (-10,426.0%)
|
-100.0K
-100.0K – -100.0K
+0.0% YoY
|
-100.0K
-100.0K – -100.0K
+0.0% YoY
|
-51.04M
-51.04M – -51.04M
-50,943.0% YoY
|
-74.5K
-74.5K – -74.5K
+99.9% YoY
|
| Net Income |
-15.23M
est: 4.14M (-467.8%)
|
-7.50M
|
-8.26M
|
-9.81M
est: -640.83M (+98.5%)
|
-9.40M
est: -166.56M (+94.4%)
|
-14.40M
est: -23.90M (+39.8%)
|
-19.13M
est: -20.35M (+6.0%)
|
-19.45M
est: -23.71M (+18.0%)
|
-28.96M
est: -908.5K (-3,087.7%)
|
-17.32M
est: -48.51M (+64.3%)
|
-13.96M
est: -12.53M (-11.4%)
|
-2.38M
-2.38M – -2.38M
+81.0% YoY
|
-2.38M
-2.38M – -2.38M
+0.0% YoY
|
-2.36M
-2.36M – -2.36M
+0.8% YoY
|
-2.44M
-2.44M – -2.44M
-3.4% YoY
|
| SGA |
7.15M
est: 15.93M (-55.1%)
|
7.68M
est: 6.96B (-99.9%)
|
6.57M
est: 15.74B (-100.0%)
|
6.20M
est: 18.09M (-65.7%)
|
7.04M
est: 19.17M (-63.3%)
|
8.65M
est: 13.36M (-35.2%)
|
8.67M
est: 9.61M (-9.8%)
|
13.50M
est: 19.10M (-29.3%)
|
21.14M
est: 17.40M (+21.5%)
|
13.71M
est: 17.31M (-20.8%)
|
7.70M
est: 8.66M (-11.0%)
|
8.66M
8.66M – 8.66M
+0.0% YoY
|
8.66M
8.66M – 8.66M
+0.0% YoY
|
4.42B
4.42B – 4.42B
+50,943.0% YoY
|
6.44M
6.44M – 6.44M
-99.9% YoY
|
| EPS |
-1,149.98
est: 7.39 (-15,657.1%)
|
-543.05
|
-463.19
|
-355.19
est: -1,144.00 (+69.0%)
|
-93.71
est: -297.33 (+68.5%)
|
-16.41
est: -42.67 (+61.5%)
|
-14.67
est: -36.33 (+59.6%)
|
-14.69
est: -42.33 (+65.3%)
|
-21.64
est: -0.56 (-3,755.0%)
|
-11.22
est: -29.97 (+62.5%)
|
-8.62
est: -7.74 (-11.3%)
|
-1.47
-1.47 – -1.47
+81.0% YoY
|
-1.47
-1.47 – -1.47
+0.0% YoY
|
-1.46
-1.46 – -1.46
+0.8% YoY
|
-1.51
-1.51 – -1.51
-3.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-12.58M
OE per share TTM
-4.99
Owner's Yield
-1,192.70%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
1,991.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
11
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Armistice Capital, LLC | 4.33M | 6.84% | — | 4.33M | — | — | IA, OO | Delaware | 2024-11-14 | ↗ |
| 2 | Steven Boyd | 4.33M | 6.84% | — | 4.33M | — | — | HC, IN | Delaware | 2024-11-14 | ↗ |
| 3 | Todd Deutsch | 1.72M | 3.50% | 1.72M | — | 1.72M | — | IN | — | 2023-07-27 | ↗ |
| 4 | 13G | 1.67M | 6.90% | — | 1.67M | — | 1.67M | IN | Ontario, Canada | 2016-09-07 | ↗ |
| 5 | Ted D. Kellner | 1.44M | 3.00% | 394.0K | 1.05M | 394.0K | 1.05M | IN | — | 2023-07-27 | ↗ |
| 6 | Anson Funds Management LP | 1.28M | 9.90% | — | 1.28M | — | 1.28M | IA, PN | Texas | 2019-09-30 | ↗ |
| 7 | Tax ID #43-1225960 | 1.00M | 4.00% | 1.00M | — | 1.00M | — | IA | Missouri Corporation | 1999-02-09 | ↗ |
| 8 | QVT Financial LP | 535.0K | 5.02% | — | 666.7K | — | 666.7K | PN | Cayman Islands | 2016-09-01 | ↗ |
| 9 | Sabby Healthcare Master Fund, Ltd. | 500.0K | 1.09% | — | 500.0K | — | 500.0K | CO | Cayman Islands | 2018-04-24 | ↗ |
| 10 | Hudson Bay Capital Management LP | 7.7K | 0.02% | — | 7.7K | — | — | PN | State of Delaware | 2021-02-08 | ↗ |
| 11 | Sander Gerber | 7.7K | 0.02% | — | 7.7K | — | — | IN | United States | 2021-02-08 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ADVISOR GROUP HOLDINGS, INC. | — -1.0K (-100.0%) | — -200.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 23 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
2.8K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+2,800
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | Equels Thomas K | Director / Officer | C-Conversion | A | Common stock | 25,000 | 0.00 | — | 63,922 | D | ↗ |
| 2026-03-12 | CHEMEROW DAVID I. | Director | C-Conversion | A | Common Stock | 25,000 | 0.00 | — | 28,441 | D | ↗ |
| 2026-03-06 | Equels Thomas K | Officer | J-Other | A | Class G Warrants | 50,000 | 1.00 | 50.0K | 50,000 | D | ↗ |
| 2026-03-06 | CHEMEROW DAVID I. | Director | J-Other | A | Class G Warrants | 50,000 | 1.00 | 50.0K | 50,000 | D | ↗ |
| 2026-02-05 | CHEMEROW DAVID I. | Director | A-Award | A | Common Stock | 2,800 | 1.23 | 3.4K | 3,441 | I | ↗ |
| 2025-07-17 | KELLNER TED D | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-13 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 107 | 7.70 | 823.58 | 38,885 | D | ↗ |
| 2025-06-12 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 103 | 8.70 | 896.10 | 38,675 | D | ↗ |
| 2025-04-11 | MITCHELL WILLIAM M | Director | P-Purchase | A | Common Stock | 196,851 | 0.03 | 5.0K | 521,723 | D | ↗ |
| 2025-04-11 | KELLNER TED D | Director | P-Purchase | A | Common Stock | 1,968,504 | 0.03 | 50.0K | 1,969,504 | D | ↗ |
| 2025-04-11 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 1,968,504 | 0.03 | 50.0K | 3,867,533 | D | ↗ |
| 2025-04-04 | Rodino Peter W III | Officer | P-Purchase | A | Common Stock | 500 | 0.09 | 43.50 | 401,762 | D | ↗ |
| 2025-04-04 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 41,000 | 0.06 | 2.6K | 1,899,029 | D | ↗ |
| 2025-03-14 | MITCHELL WILLIAM M | Director | A-Award | A | Common Stock | 44,899 | 0.12 | 5.2K | 324,872 | D | ↗ |
| 2025-03-14 | CHEMEROW DAVID I. | Director | A-Award | A | Common Stock | 44,899 | 0.12 | 5.2K | 64,189 | D | ↗ |
| 2025-03-14 | BRYAN NANCY | Director | A-Award | A | Common Stock | 44,899 | 0.12 | 5.2K | 291,882 | D | ↗ |
| 2025-03-05 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.13 | 6.7K | 1,858,029 | D | ↗ |
| 2025-03-04 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 44,000 | 0.12 | 5.1K | 1,808,029 | D | ↗ |
| 2025-02-28 | MITCHELL WILLIAM M | Director | A-Award | A | Common Stock | 38,580 | 0.14 | 5.2K | 279,973 | D | ↗ |
| 2025-02-28 | CHEMEROW DAVID I. | Director | A-Award | A | Common Stock | 19,290 | 0.14 | 2.6K | 19,290 | D | ↗ |
| 2025-02-28 | BRYAN NANCY | Director | A-Award | A | Common Stock | 38,580 | 0.14 | 5.2K | 246,983 | D | ↗ |
| 2025-02-24 | CHEMEROW DAVID I. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-02-14 | MITCHELL WILLIAM M | Director | A-Award | A | Common Stock | 43,330 | 0.12 | 5.2K | 241,393 | D | ↗ |
| 2025-02-14 | BRYAN NANCY | Director | A-Award | A | Common Stock | 43,330 | 0.12 | 5.2K | 208,403 | D | ↗ |
| 2025-01-31 | MITCHELL WILLIAM M | Director | A-Award | D | Common Stock | 25,797 | 0.20 | 5.2K | 198,063 | D | ↗ |
| 2025-01-31 | BRYAN NANCY | Director | A-Award | A | Common Stock | 25,797 | 0.20 | 5.2K | 165,073 | D | ↗ |
| 2025-01-15 | MITCHELL WILLIAM M | Director | A-Award | A | Common Stock | 27,412 | 0.19 | 5.2K | 172,266 | D | ↗ |
| 2025-01-15 | BRYAN NANCY | Director | A-Award | A | Common Stock | 27,412 | 0.19 | 5.2K | 139,276 | D | ↗ |
| 2024-12-31 | MITCHELL WILLIAM M | Director | A-Award | A | Common Stock | 26,305 | 0.20 | 5.2K | 144,854 | D | ↗ |
| 2024-12-31 | BRYAN NANCY | Director | A-Award | A | Common Stock | 26,305 | 0.20 | 5.2K | 111,864 | D | ↗ |
| 2024-12-31 | APPELROUTH STEWART | Director | A-Award | A | Common Stock | 8,768 | 0.20 | 1.7K | 388,729 | D | ↗ |
| 2024-12-19 | MITCHELL WILLIAM M | Director | S-Sale | D | Common Stock | 4,580 | 0.19 | 883.94 | 118,549 | D | ↗ |
| 2024-12-19 | KELLNER TED D | Director | — | — | Common Stock | 0 | 0.00 | — | 1,000 | D | ↗ |
| 2024-12-18 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 22,727 | 0.21 | 4.7K | 1,680,695 | D | ↗ |
| 2024-12-13 | MITCHELL WILLIAM M | Director | A-Award | A | Common Stock | 24,452 | 0.21 | 5.2K | 123,803 | D | ↗ |
| 2024-12-13 | BRYAN NANCY | Director | A-Award | A | Common Stock | 24,452 | 0.21 | 5.2K | 85,559 | D | ↗ |
| 2024-12-13 | APPELROUTH STEWART | Director | A-Award | A | Common Stock | 24,452 | 0.21 | 5.2K | 379,961 | D | ↗ |
| 2024-12-02 | MITCHELL WILLIAM M | Director | A-Award | A | Common Stock | 22,645 | 0.23 | 5.2K | 99,351 | D | ↗ |
| 2024-12-02 | BRYAN NANCY | Director | A-Award | A | Common Stock | 22,645 | 0.23 | 5.2K | 61,107 | D | ↗ |
| 2024-12-02 | APPELROUTH STEWART | Director | A-Award | A | Common Stock | 22,645 | 0.23 | 5.2K | 344,397 | D | ↗ |
| 2024-11-21 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.21 | 4.2K | 1,657,968 | D | ↗ |
| 2024-11-20 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 85,000 | 0.20 | 16.9K | 1,637,968 | D | ↗ |
| 2024-11-20 | APPELROUTH STEWART | Director | P-Purchase | A | Common Stock | 81,953 | 0.19 | 15.8K | 321,752 | D | ↗ |
| 2024-09-16 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 0.30 | 1.5K | 1,493,042 | — | ↗ |
| 2024-09-13 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.31 | 6.2K | 1,488,042 | — | ↗ |
| 2024-09-11 | Equels Thomas K | Director / Officer | A-Award | A | Common Stock | 312,500 | 0.32 | 100.0K | 1,468,042 | — | ↗ |
| 2024-08-12 | Rodino Peter W III | Officer | A-Award | A | Common Stock | 188,679 | 0.27 | 50.0K | 401,262 | — | ↗ |
| 2024-08-12 | Equels Thomas K | Director / Officer | A-Award | A | Common Stock | 377,358 | 0.27 | 100.0K | 1,155,542 | — | ↗ |
| 2024-05-06 | Rodino Peter W III | Officer | P-Purchase | A | Common Stock | 30,865 | 0.41 | 12.5K | 212,583 | — | ↗ |
| 2024-05-06 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 61,729 | 0.41 | 25.0K | 778,184 | — | ↗ |
| 2024-03-21 | BRYAN NANCY | Director | P-Purchase | A | Common Stock | 38,462 | 0.39 | 15.0K | 38,462 | — | ↗ |
| 2024-03-15 | Rodino Peter W III | Officer | P-Purchase | A | Common Stock | 37,879 | 0.33 | 12.5K | 181,718 | — | ↗ |
| 2024-03-15 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 75,758 | 0.33 | 25.0K | 716,455 | — | ↗ |
| 2024-03-15 | APPELROUTH STEWART | Director | P-Purchase | A | Common Stock | 90,910 | 0.33 | 30.0K | 239,765 | — | ↗ |
| 2023-11-30 | Rodino Peter W III | Officer | A-Award | A | Options | 100,000 | 0.47 | 47.0K | 100,000 | — | ↗ |
| 2023-11-30 | Equels Thomas K | Director / Officer | A-Award | A | Options | 300,000 | 0.47 | 141.0K | 300,000 | — | ↗ |
| 2023-11-27 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 33,861 | 0.44 | 15.0K | 640,697 | — | ↗ |
| 2023-09-29 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 22,676 | 0.44 | 10.0K | 606,836 | — | ↗ |
| 2023-08-25 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 8,222 | 0.67 | 5.5K | 584,160 | — | ↗ |
| 2023-08-24 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 14,993 | 0.67 | 10.0K | 575,938 | — | ↗ |
| 2023-07-17 | Equels Thomas K | Director / Officer | P-Purchase | A | Common Stock | 16,950 | 0.59 | 10.0K | 560,945 | — | ↗ |
| 2023-03-28 | BRYAN NANCY | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-03-10 | APPELROUTH STEWART | Director | J-Other | D | Common Stock | 68,208 | 1.23 | 83.9K | 148,855 | — | ↗ |
| 2023-03-08 | APPELROUTH STEWART | Director | J-Other | A | Options | 295 | 18.04 | 5.3K | 295 | — | ↗ |
| 2023-03-03 | Dickey Robert IV | Officer | — | D | Options | 50,000 | 0.70 | 35.0K | 0 | — | ↗ |
| 2023-01-03 | Rodino Peter W III | Officer | P-Purchase | A | Common Stock | 80,646 | 0.31 | 25.0K | 143,839 | — | ↗ |
| 2023-01-03 | Equels Thomas K | Officer | P-Purchase | A | Common Stock | 161,291 | 0.31 | 50.0K | 543,995 | — | ↗ |
| 2023-01-03 | APPELROUTH STEWART | Director | P-Purchase | A | Common Stock | 80,646 | 0.31 | 25.0K | 217,063 | — | ↗ |
| 2022-11-30 | Rodino Peter W III | Officer | A-Award | A | Options | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2022-11-30 | MITCHELL WILLIAM M | Director | A-Award | A | Options | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-11-30 | Equels Thomas K | Officer | A-Award | A | Options | 300,000 | 0.00 | — | 300,000 | — | ↗ |
| 2022-11-30 | APPELROUTH STEWART | Director | A-Award | A | Options | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-07-18 | Equels Thomas K | Officer | A-Award | A | Common Stock | 32,895 | 0.76 | 25.0K | 382,704 | — | ↗ |
| 2022-04-25 | Rodino Peter W III | Officer | A-Award | A | Common Stock | 4,902 | 1.02 | 5.0K | 63,193 | — | ↗ |
| 2022-04-25 | Equels Thomas K | Officer | A-Award | A | Common Stock | 49,020 | 1.02 | 50.0K | 349,809 | — | ↗ |
| 2022-04-25 | APPELROUTH STEWART | Director | A-Award | A | Common Stock | 24,500 | 1.07 | 26.2K | 136,417 | — | ↗ |
| 2022-04-04 | LINTAL ELLEN M | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-03-03 | Rodino Peter W III | Officer | A-Award | A | Options | 50,000 | 0.70 | 35.0K | 50,000 | — | ↗ |
| 2022-03-03 | MITCHELL WILLIAM M | Director | A-Award | A | Options | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-03-03 | LINTAL ELLEN M | Officer | A-Award | A | Options | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2022-03-03 | Equels Thomas K | Director / Officer | A-Award | A | Options | 50,000 | 0.70 | 35.0K | 50,000 | — | ↗ |
| 2022-03-03 | APPELROUTH STEWART | Director | A-Award | A | Options | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2021-12-13 | Equels Thomas K | Director / Officer | A-Award | A | Common Stock | 21,552 | 1.16 | 25.0K | 300,789 | — | ↗ |
| 2021-12-10 | Equels Thomas K | Officer | A-Award | A | Common Stock | 11,811 | 1.27 | 15.0K | 279,237 | — | ↗ |
| 2021-11-30 | RODINO III PETER W. | Officer | A-Award | A | Options | 100,000 | 1.44 | 144.0K | 100,000 | — | ↗ |
| 2021-11-30 | LINTAL ELLEN M | Officer | A-Award | A | Options | 100,000 | 1.44 | 144.0K | 100,000 | — | ↗ |
| 2021-11-24 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 11,627 | 1.29 | 15.0K | 267,426 | — | ↗ |
| 2021-11-24 | APPELROUTH STEWART | Director | A-Award | A | Common Stock | 19,379 | 1.29 | 25.0K | 111,917 | — | ↗ |
| 2021-11-23 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 11,194 | 1.34 | 15.0K | 255,799 | — | ↗ |
| 2021-11-19 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 10,204 | 1.47 | 15.0K | 244,605 | — | ↗ |
| 2021-11-17 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 9,146 | 1.64 | 15.0K | 234,401 | — | ↗ |
| 2021-11-11 | MITCHELL WILLIAM M | Director | A-Award | A | Options | 50,000 | 1.71 | 85.5K | 50,000 | — | ↗ |
| 2021-11-11 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Options | 300,000 | 1.71 | 513.0K | 300,000 | — | ↗ |
| 2021-11-11 | APPELROUTH STEWART | Director | A-Award | A | Options | 50,000 | 1.71 | 85.5K | 50,000 | — | ↗ |
| 2021-07-16 | EQUELS THOMAS K. | Director / Officer | P-Purchase | A | Common Stock | 15,625 | 1.92 | 30.0K | 225,255 | — | ↗ |
| 2021-02-25 | APPELROUTH STEWART | Director | P-Purchase | A | Common Stock | 10,638 | 2.35 | 25.0K | 92,538 | — | ↗ |
| 2021-02-24 | EQUELS THOMAS K. | Director / Officer | P-Purchase | A | Common Stock | 11,062 | 2.26 | 25.0K | 209,630 | — | ↗ |
| 2020-12-17 | EQUELS THOMAS K. | Director / Officer | P-Purchase | A | Common Stock | 14,535 | 1.72 | 25.0K | 198,568 | — | ↗ |
| 2020-12-09 | RODINO III PETER W. | Officer | A-Award | A | Options | 75,000 | 1.85 | 138.8K | 75,000 | — | ↗ |
| 2020-12-09 | LINTAL ELLEN M | Officer | A-Award | A | Options | 75,000 | 1.85 | 138.8K | 75,000 | — | ↗ |
| 2020-11-11 | EQUELS THOMAS K. | Officer | A-Award | A | Options | 300,000 | 1.96 | 588.0K | 300,000 | — | ↗ |
| 2020-09-03 | EQUELS THOMAS K. | Director / Officer | P-Purchase | A | Common Stock | 12,316 | 2.03 | 25.0K | 184,033 | — | ↗ |
| 2020-08-21 | EQUELS THOMAS K. | Director / Officer | P-Purchase | A | Common Stock | 10,730 | 2.33 | 25.0K | 171,717 | — | ↗ |
| 2020-08-12 | MITCHELL WILLIAM M | Director | A-Award | A | Options | 50,000 | 2.77 | 138.5K | 50,000 | — | ↗ |
| 2020-08-12 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Options | 300,000 | 3.05 | 915.0K | 300,000 | — | ↗ |
| 2020-08-12 | APPELROUTH STEWART | Director | A-Award | A | Options | 50,000 | 2.77 | 138.5K | 50,000 | — | ↗ |
| 2019-12-31 | RODINO III PETER W. | Officer | A-Award | A | Common Stock | 6,879 | 0.53 | 3.6K | 58,290 | — | ↗ |
| 2019-12-31 | LINTAL ELLEN M | Officer | A-Award | A | Common Stock | 3,931 | 0.53 | 2.1K | 22,892 | — | ↗ |
| 2019-12-31 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 14,741 | 0.53 | 7.8K | 160,990 | — | ↗ |
| 2019-12-13 | RODINO III PETER W. | Officer | A-Award | A | Common Stock | 8,381 | 0.44 | 3.6K | 51,411 | — | ↗ |
| 2019-12-13 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 8,358 | 0.45 | 3.8K | 76,407 | — | ↗ |
| 2019-12-13 | LINTAL ELLEN M | Officer | A-Award | A | Common Stock | 4,789 | 0.44 | 2.1K | 18,961 | — | ↗ |
| 2019-12-13 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 17,960 | 0.44 | 7.8K | 146,249 | — | ↗ |
| 2019-12-13 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 8,358 | 0.45 | 3.8K | 81,326 | — | ↗ |
| 2019-11-29 | RODINO III PETER W. | Officer | A-Award | A | Common Stock | 9,115 | 0.40 | 3.6K | 43,030 | — | ↗ |
| 2019-11-29 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 9,503 | 0.40 | 3.8K | 68,049 | — | ↗ |
| 2019-11-29 | LINTAL ELLEN M | Officer | A-Award | A | Common Stock | 5,208 | 0.40 | 2.1K | 14,172 | — | ↗ |
| 2019-11-29 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 19,531 | 0.40 | 7.8K | 128,289 | — | ↗ |
| 2019-11-29 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 9,503 | 0.40 | 3.8K | 72,968 | — | ↗ |
| 2019-11-15 | RODINO III PETER W. | Officer | A-Award | A | Common Stock | 7,752 | 0.47 | 3.6K | 33,915 | — | ↗ |
| 2019-11-15 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 8,264 | 0.46 | 3.8K | 58,546 | — | ↗ |
| 2019-11-15 | LINTAL ELLEN M | Officer | A-Award | A | Common Stock | 4,433 | 0.47 | 2.1K | 8,964 | — | ↗ |
| 2019-11-15 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 16,622 | 0.47 | 7.8K | 108,758 | — | ↗ |
| 2019-11-15 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 8,264 | 0.46 | 3.8K | 63,465 | — | ↗ |
| 2019-10-31 | RODINO III PETER W. | Officer | A-Award | A | Common Stock | 7,297 | 0.50 | 3.6K | 26,163 | — | ↗ |
| 2019-10-31 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 7,603 | 0.50 | 3.8K | 50,282 | — | ↗ |
| 2019-10-31 | LINTAL ELLEN M | Officer | A-Award | A | Common Stock | 4,167 | 0.50 | 2.1K | 4,531 | — | ↗ |
| 2019-10-31 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 15,625 | 0.50 | 7.8K | 92,136 | — | ↗ |
| 2019-10-31 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 7,603 | 0.50 | 3.8K | 55,201 | — | ↗ |
| 2019-10-17 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 6,911 | 0.55 | 3.8K | 47,598 | — | ↗ |
| 2019-10-15 | RODINO III PETER W. | Officer | A-Award | A | Common Stock | 6,286 | 0.58 | 3.6K | 18,866 | — | ↗ |
| 2019-10-15 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 13,470 | 0.58 | 7.8K | 76,511 | — | ↗ |
| 2019-10-02 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 5,002 | 0.76 | 3.8K | 35,768 | — | ↗ |
| 2019-10-02 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 5,002 | 0.76 | 3.8K | 40,687 | — | ↗ |
| 2019-09-16 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 2,033 | 1.87 | 3.8K | 30,766 | — | ↗ |
| 2019-09-16 | LINTAL ELLEN M | Officer | — | D | Common Stock | 0 | 0.00 | — | 364 | — | ↗ |
| 2019-09-16 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 2,033 | 1.87 | 3.8K | 35,685 | — | ↗ |
| 2019-09-03 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 2,112 | 1.80 | 3.8K | 28,733 | — | ↗ |
| 2019-09-03 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 2,112 | 1.80 | 3.8K | 33,652 | — | ↗ |
| 2019-08-16 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 2,001 | 1.90 | 3.8K | 26,621 | — | ↗ |
| 2019-08-16 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 2,001 | 1.90 | 3.8K | 31,540 | — | ↗ |
| 2019-07-31 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 1,618 | 2.35 | 3.8K | 24,620 | — | ↗ |
| 2019-07-31 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 1,618 | 2.35 | 3.8K | 29,539 | — | ↗ |
| 2019-07-16 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 920 | 4.13 | 3.8K | 22,624 | — | ↗ |
| 2019-07-16 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 920 | 4.13 | 3.8K | 28,494 | — | ↗ |
| 2019-07-03 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 866 | 4.39 | 3.8K | 21,704 | — | ↗ |
| 2019-07-03 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 866 | 4.39 | 3.8K | 27,574 | — | ↗ |
| 2019-06-27 | EQUELS THOMAS K. | Director / Officer | P-Purchase | A | Common Stock | 2,632 | 4.37 | 11.5K | 63,041 | — | ↗ |
| 2019-06-21 | STRAYER DAVID R | Officer | P-Purchase | A | Common Stock | 2,481 | 4.03 | 10.0K | 5,420 | — | ↗ |
| 2019-06-21 | SPRINGATE WAYNE S | Officer | P-Purchase | A | Common Stock | 5,211 | 4.03 | 21.0K | 8,672 | — | ↗ |
| 2019-06-21 | RODINO III PETER W. | Officer | P-Purchase | A | Common Stock | 8,695 | 4.03 | 35.0K | 12,590 | — | ↗ |
| 2019-06-21 | MITCHELL WILLIAM M | Director | P-Purchase | A | Common Stock | 9,677 | 4.03 | 39.0K | 20,838 | — | ↗ |
| 2019-06-21 | EQUELS THOMAS K. | Director / Officer | P-Purchase | A | Common Stock | 29,404 | 4.03 | 118.5K | 60,409 | — | ↗ |
| 2019-06-21 | APPELROUTH STEWART | Director | P-Purchase | A | Common Stock | 9,677 | 4.03 | 39.0K | 26,708 | — | ↗ |
| 2019-06-14 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 711 | 5.35 | 3.8K | 11,161 | — | ↗ |
| 2019-06-14 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 711 | 5.35 | 3.8K | 17,031 | — | ↗ |
| 2019-06-03 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 38,013 | 0.10 | 3.8K | 119,805 | — | ↗ |
| 2019-06-03 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 38,013 | 0.10 | 3.8K | 378,096 | — | ↗ |
| 2019-05-16 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 25,342 | 0.15 | 3.8K | 81,792 | — | ↗ |
| 2019-05-16 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 25,342 | 0.15 | 3.8K | 340,083 | — | ↗ |
| 2019-05-09 | MITCHELL WILLIAM M | Director | C-Conversion | A | Common Stock | 140,000 | 0.00 | — | 459,805 | — | ↗ |
| 2019-05-08 | STRAYER DAVID R | Officer | C-Conversion | A | Common Stock | 35,000 | 0.00 | — | 129,304 | — | ↗ |
| 2019-05-08 | SPRINGATE WAYNE S | Officer | C-Conversion | A | Common Stock | 35,000 | 0.00 | — | 152,273 | — | ↗ |
| 2019-05-08 | RODINO III PETER W. | Officer | C-Conversion | A | Common Stock | 63,000 | 0.00 | — | 171,373 | — | ↗ |
| 2019-05-08 | PASCALE ADAM | Officer | C-Conversion | A | Common Stock | 35,000 | 0.00 | — | 147,148 | — | ↗ |
| 2019-05-08 | EQUELS THOMAS K. | Director / Officer | C-Conversion | A | Common Stock | 227,500 | 0.00 | — | 1,364,207 | — | ↗ |
| 2019-05-08 | APPELROUTH STEWART | Director | C-Conversion | A | Common Stock | 200,000 | 0.00 | — | 718,096 | — | ↗ |
| 2019-05-06 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 18,101 | 0.21 | 3.8K | 56,450 | — | ↗ |
| 2019-05-06 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 18,101 | 0.21 | 3.8K | 314,741 | — | ↗ |
| 2019-05-03 | MITCHELL WILLIAM M | Director | J-Other | A | Common Stock | 27,152 | 0.14 | 3.8K | 38,349 | — | ↗ |
| 2019-05-03 | APPELROUTH STEWART | Director | J-Other | A | Common Stock | 27,152 | 0.14 | 3.8K | 296,640 | — | ↗ |
| 2019-03-25 | STRAYER DAVID R | Officer | C-Conversion | A | Common Stock | 50,000 | 1,000.00 | 50.00M | 94,304 | — | ↗ |
| 2019-03-25 | SPRINGATE WAYNE S | Officer | C-Conversion | A | Common Stock | 50,000 | 1,000.00 | 50.00M | 117,273 | — | ↗ |
| 2019-03-25 | APPELROUTH STEWART | Director | C-Conversion | A | Common Stock | 140,000 | 1,000.00 | 140.00M | 518,096 | — | ↗ |
| 2019-03-19 | EQUELS THOMAS K. | Director / Officer | P-Purchase | A | Common Stock | 13,400 | 0.18 | 2.4K | 811,707 | — | ↗ |
| 2019-03-18 | RODINO III PETER W. | Officer | C-Conversion | A | Common Stock | 90,000 | 1,000.00 | 90.00M | 108,373 | — | ↗ |
| 2019-03-18 | PASCALE ADAM | Officer | C-Conversion | A | Common Stock | 50,000 | 1,000.00 | 50.00M | 112,148 | — | ↗ |
| 2019-03-18 | MITCHELL WILLIAM M | Director | C-Conversion | A | Common Stock | 200,000 | 1,000.00 | 200.00M | 319,805 | — | ↗ |
| 2019-03-18 | EQUELS THOMAS K. | Director / Officer | C-Conversion | A | Common Stock | 325,000 | 1,000.00 | 325.00M | 1,136,707 | — | ↗ |
| 2019-03-04 | STRAYER DAVID R | Officer | X-InTheMoney | A | Series B Convertible Preferred Stock | 10 | 1,000.00 | 10.0K | 10 | — | ↗ |
| 2019-03-04 | MITCHELL WILLIAM M | Director | X-InTheMoney | A | Warrants | 200,000 | 1,000.00 | 200.00M | 200,000 | — | ↗ |
| 2019-02-28 | SPRINGATE WAYNE S | Officer | X-InTheMoney | A | Warrants | 50,000 | 1,000.00 | 50.00M | 50,000 | — | ↗ |
| 2019-02-28 | APPELROUTH STEWART | Director | X-InTheMoney | A | Subr Rights(to buy) | 40 | 1,000.00 | 40.0K | 0 | — | ↗ |
| 2019-02-27 | RODINO III PETER W. | Officer | X-InTheMoney | A | Series B Convertible Preferred Stock | 18 | 1,000.00 | 18.0K | 18 | — | ↗ |
| 2019-02-27 | PASCALE ADAM | Officer | X-InTheMoney | A | Series B Convertible Preferred Stock | 10 | 1,000.00 | 10.0K | 10 | — | ↗ |
| 2019-02-27 | EQUELS THOMAS K. | Director / Officer | X-InTheMoney | A | Warrants | 325,000 | 1,000.00 | 325.00M | 325,000 | — | ↗ |
| 2019-01-28 | STRAYER DAVID R | Officer | A-Award | A | Options to buy Common Stock | 184,659 | 0.22 | 40.6K | 184,659 | — | ↗ |
| 2019-01-28 | SPRINGATE WAYNE S | Officer | A-Award | A | Options to buy Common Stock | 142,046 | 0.22 | 31.3K | 142,046 | — | ↗ |
| 2019-01-28 | RODINO III PETER W. | Officer | A-Award | A | Options to buy Common Stock | 198,864 | 0.22 | 43.8K | 198,864 | — | ↗ |
| 2019-01-28 | PASCALE ADAM | Officer | A-Award | A | Options to buy Common Stock | 142,046 | 0.22 | 31.3K | 142,046 | — | ↗ |
| 2019-01-28 | MITCHELL WILLIAM M | Director | A-Award | A | Options to buy Common Stock | 207,343 | 0.22 | 45.6K | 207,343 | — | ↗ |
| 2019-01-28 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Options to buy Common Stock | 426,136 | 0.22 | 93.7K | 426,136 | — | ↗ |
| 2019-01-28 | APPELROUTH STEWART | Director | A-Award | A | Options to buy Common Stock | 207,343 | 0.22 | 45.6K | 207,343 | — | ↗ |
| 2018-11-30 | EQUELS THOMAS K. | Director / Officer | P-Purchase | A | Common Stock | 50 | 0.19 | 9.69 | 791,673 | — | ↗ |
| 2018-11-27 | STRAYER DAVID R | Officer | A-Award | A | Common Stock | 2,500 | 0.00 | — | 44,304 | — | ↗ |
| 2018-11-27 | SPRINGATE WAYNE S | Officer | A-Award | A | Common Stock | 2,500 | 0.00 | — | 67,273 | — | ↗ |
| 2018-11-27 | RODINO III PETER W. | Officer | A-Award | A | Common Stock | 2,500 | 0.00 | — | 18,373 | — | ↗ |
| 2018-11-27 | MITCHELL WILLIAM M | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 11,197 | — | ↗ |
| 2018-11-27 | EQUELS THOMAS K. | Director / Officer | A-Award | A | Common Stock | 2,500 | 0.00 | — | 778,307 | — | ↗ |
| 2018-11-27 | APPELROUTH STEWART | Director | A-Award | A | Common Stock | 2,500 | 0.00 | — | 269,488 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-5.0K
Shares Outstanding
3.40M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | N. Bryan Director | — | — | 15.6K | — | — | — | 125.0K | 12.50% | ↗ |
| 2 | 2024 | W. Mitchell Chairman of the Board | — | — | 15.6K | — | — | — | 125.0K | 12.50% | ↗ |
| 3 | 2024 | S. Appelrouth Director | — | — | 12.2K | — | — | — | 121.5K | 10.00% | ↗ |
| 4 | 2020 | W. Mitchell Chairman of the Board | — | — | — | 112.2K | — | — | 294.6K | 38.07% | ↗ |
| 5 | 2020 | S. Appelrouth Director | — | — | — | 112.2K | — | — | 294.6K | 38.07% | ↗ |
| 6 | 2019 | W. Mitchell Chairman of the Board | — | — | — | 37.8K | — | — | 220.2K | 17.15% | ↗ |
| 7 | 2019 | S. Appelrouth Director | — | — | — | 37.8K | — | — | 220.2K | 17.15% | ↗ |
| 8 | 2018 | Thomas K. Equels CEO & President | 751.0K | 18.4K | 500.00 | 335.7K | — | 65.9K | 1.17M | 28.70% | ↗ |
| 9 | 2018 | Peter Rodino General Counsel and Secretary | 351.0K | — | 500.00 | 138.6K | — | 36.7K | 526.8K | 26.41% | ↗ |
| 10 | 2018 | Adam Pascale CFO | 251.0K | — | 500.00 | 100.0K | — | 41.0K | 392.5K | 25.60% | ↗ |
| 11 | 2018 | W. Mitchell Chairman of the Board | — | — | 500.00 | 193.4K | — | — | 308.0K | 62.97% | ↗ |
| 12 | 2018 | S. Appelrouth Director | — | — | 500.00 | 193.4K | — | — | 308.0K | 62.97% | ↗ |
| 13 | 2017 | Thomas K. Equels CEO & President | 712.5K | 22.1K | — | 174.1K | — | 78.6K | 987.2K | 17.63% | ↗ |
| 14 | 2017 | Peter Rodino General Counsel and Secretary | 332.5K | — | — | 17.5K | — | 48.7K | 398.7K | 4.39% | ↗ |
| 15 | 2017 | Adam Pascale CFO | 234.5K | — | — | 12.5K | — | 48.4K | 295.4K | 4.23% | ↗ |
| 16 | 2016 | Thomas K. Equels CEO & President | 503.1K | 170.3K | — | 27.3K | — | 84.5K | 785.2K | 3.48% | ↗ |
| 17 | 2016 | David Strayer CSO & Medical Director | 284.6K | — | — | 12.6K | — | 32.2K | 329.4K | 3.82% | ↗ |
| 18 | 2016 | Adam Pascale CFO | 190.8K | — | — | 12.6K | — | 32.0K | 235.4K | 5.35% | ↗ |
| 19 | 2016 | Peter Rodino General Counsel and Secretary | 208.5K | — | — | 12.6K | — | — | 221.1K | 5.69% | ↗ |
| 20 | 2015 | William A. Carter, former CEO, President & CSO | 1.19M | 262.1K | — | 75.9K | — | 173.5K | 1.70M | 4.47% | ↗ |
| 21 | 2015 | Thomas K. Equels CEO & President | 719.3K | 262.1K | — | 45.5K | — | 95.0K | 1.12M | 4.06% | ↗ |
| 22 | 2015 | Thomas K. Equels CEO, President, General Counsel | 719.3K | 262.1K | — | 45.5K | — | 95.0K | 1.12M | 4.06% | ↗ |
| 23 | 2015 | David Strayer CSO & Medical Director | 269.5K | — | — | — | — | 44.9K | 314.3K | 0.00% | ↗ |
| 24 | 2015 | Adam Pascale CFO | 154.0K | — | — | — | — | 38.3K | 192.3K | 0.00% | ↗ |
| 25 | 2015 | Peter Rodino General Counsel and Secretary | 182.5K | — | — | — | — | — | 182.5K | 0.00% | ↗ |
| 26 | 2014 | William A. Carter, former CEO, President & CSO | 1.19M | 891.5K | — | 135.0K | — | 153.1K | 2.36M | 5.71% | ↗ |
| 27 | 2014 | Thomas K. Equels CEO & President | 719.3K | 775.0K | — | 69.2K | — | 105.0K | 1.67M | 4.15% | ↗ |
| 28 | 2014 | Thomas K. Equels CEO, President, General Counsel | 719.3K | 775.0K | — | 69.2K | — | 105.0K | 1.67M | 4.15% | ↗ |
| 29 | 2014 | David Strayer CSO & Medical Director | 269.5K | 67.4K | — | 746.00 | — | 29.7K | 367.3K | 0.20% | ↗ |
| 30 | 2014 | Adam Pascale CFO | 143.9K | 33.5K | — | 10.3K | — | 36.0K | 223.7K | 4.62% | ↗ |
| 31 | 2013 | William A. Carter, former CEO, President & CSO | 1.17M | 12.4K | — | 125.7K | — | 147.7K | 1.45M | 8.65% | ↗ |
| 32 | 2013 | Thomas K. Equels CEO, President, General Counsel | 708.6K | 12.4K | — | 86.8K | — | 95.3K | 903.2K | 9.61% | ↗ |
| 33 | 2013 | David Strayer CSO & Medical Director | 265.5K | — | — | — | — | 25.6K | 291.1K | 0.00% | ↗ |
| 34 | 2008 | William. A. Carter, Chief Executive Officer | 664.6K | — | — | 316.6K | — | 106.1K | 1.09M | 29.12% | ↗ |
| 35 | 2008 | Robert. E. Peterson, Chief Financial Officer | 259.2K | — | — | — | — | — | 259.2K | 0.00% | ↗ |
| 36 | 2008 | David. R. Strayer, Medical Director | 201.4K | — | — | 16.2K | — | — | 217.6K | 7.43% | ↗ |
| 37 | 2008 | Russel Lander, VP of Quality Assurance | 178.0K | — | — | — | — | 9.6K | 187.6K | 0.00% | ↗ |
| 38 | 2008 | Carol A. Smith, VP of Manufacturing Quality Process Dev.. | 147.7K | — | — | 600.00 | — | 23.1K | 171.4K | 0.35% | ↗ |
| 39 | 2008 | Wayne Springate, VP of Operations | 150.0K | — | — | — | — | 7.4K | 157.4K | 0.00% | ↗ |
| 40 | 2008 | Katalin Ferencz-Biro, Senior VP of Regulatory Affairs | 145.0K | — | — | — | — | 11.5K | 156.5K | 0.00% | ↗ |
| 41 | 2008 | Robert Hansen, VP of Manufacturing | — | — | — | — | — | — | — | — | ↗ |
| 42 | 2008 | Mei-June Liao, VP of Regulatory Affairs Quality Control | — | — | — | — | — | — | — | — | ↗ |
| 43 | 2008 | Anthony A. Bonelli, Chief Operating Officer | — | — | — | — | — | — | — | — | ↗ |
| 44 | 2008 | R. Douglas Hulse | — | — | — | — | — | — | — | — | ↗ |
| 45 | 2007 | William. A. Carter, Chief Executive Officer | 637.5K | 166.2K | — | 1.69M | — | 123.1K | 2.61M | 64.56% | ↗ |
| 46 | 2007 | Anthony A. Bonelli, Chief Operating Officer | 350.0K | 87.5K | — | 59.7K | — | 33.4K | 530.6K | 11.25% | ↗ |
| 47 | 2007 | Robert. E. Peterson, Chief Financial Officer | 259.2K | 64.8K | — | 153.1K | — | — | 477.0K | 32.09% | ↗ |
| 48 | 2007 | David. R. Strayer, Medical Director | 240.3K | 50.3K | — | 79.8K | — | — | 370.5K | 21.54% | ↗ |
| 49 | 2007 | Wayne Springate, VP of Operations | 150.0K | 37.5K | — | 36.3K | — | 13.4K | 237.2K | 15.28% | ↗ |
| 50 | 2007 | Carol A. Smith, VP of Manufacturing Quality Process Dev.. | 147.7K | — | — | 34.2K | — | 30.1K | 212.0K | 16.15% | ↗ |
| 51 | 2007 | Russel Lander, VP of Quality Assurance | 178.0K | — | — | 11.7K | — | 9.6K | 199.4K | 5.89% | ↗ |
| 52 | 2007 | Katalin Ferencz-Biro, Senior VP of Regulatory Affairs | 145.0K | — | — | 11.7K | — | 14.0K | 170.7K | 6.88% | ↗ |
| 53 | 2007 | Mei-June Liao, VP of Regulatory Affairs Quality Control | — | — | — | — | — | — | — | — | ↗ |
| 54 | 2007 | Robert Hansen, VP of Manufacturing | — | — | — | — | — | — | — | — | ↗ |
| 55 | 2006 | Mei-June Liao, VP of Regulatory Affairs Quality Control | 158.4K | — | — | 9.6K | — | 18.2K | 186.2K | 5.15% | ↗ |
| 56 | 2006 | Carol A. Smith, VP of Manufacturing Quality Process Dev.. | 143.1K | — | — | 9.6K | — | 17.2K | 170.0K | 5.65% | ↗ |
| 57 | 2006 | Katalin Ferencz-Biro, Senior VP of Regulatory Affairs | — | — | — | — | — | — | — | — | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thomas K. Equels | Executive Vice Chairman, Chief Executive Officer & President | 681.3K | male |
| Peter W. Rodino | Chief Operating Officer, Executive Director of Governmental Relations, General Counsel & Secretary | 386.2K | male |
| Robert Dickey | Chief Financial Officer | 108.4K | male |
| Ann Marie E. Coverly | Director of Administration & Human Resources and Deputy Investor Relations Coordinator | — | — |
| Christopher Nicodemus FACP | Member of Scientific Advisory Board & Consulting Science Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AIM
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
